Last $24.70 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/25/14 All times are local (Market data is delayed by at least 15 minutes).

terumo corp-unspon adr (TRUMY) Snapshot

Open
$25.00
Previous Close
$24.70
Day High
$25.00
Day Low
$24.70
52 Week High
04/2/14 - $32.50
52 Week Low
05/1/14 - $19.68
Market Cap
9.4B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
379.8M
EX-Date
09/25/14
P/E TM
--
Dividend
$0.28
Dividend Yield
1.16%
Current Stock Chart for TERUMO CORP-UNSPON ADR (TRUMY)

Related News

No related news articles were found.

terumo corp-unspon adr (TRUMY) Related Businessweek News

No Related Businessweek News Found

terumo corp-unspon adr (TRUMY) Details

Terumo Corporation manufactures and sells medical products and equipment in Japan and internationally. The company operates through Cardiac and Vascular Business, Blood Management Business, and General Hospital Business segments. It offers general hospital devices and systems used for treatments at hospital bedsides and in the home, including nutrient solutions for total parenteral nutrition, safety intravenous catheters, infusion sets, infusion/syringe pumps, plastic prefilled syringes, oncology safety products and closed system solutions, blood glucose monitoring systems, needle for pen-injectors, calorie-dense liquid meals, CAPD systems, digital thermometers, stumbling-preventive socks, lancing devices for blood collection, upper arm blood pressure monitors, activity monitors, basal body thermometers, urine test strips, and support wear. It also offers products for vascular interventional treatment, including intra-vascular ultrasound systems, PTCA balloon and angiographic catheters, drug eluting stents, guidewires, introducer sheaths, endovascular coils, and peripheral stents. In addition, the company provides cardiovascular system products, such as heart-lung machines, oxygenators, platelet-rich plasma collectors/kits, artificial thoracic vascular grafts, porcine aortic valved conduits, and stent grafts. Further, it offers blood management products, including automated blood collection systems, automated blood component processing devices, blood bag systems, sterile tubing welders, and pathogen reduction technology systems; therapeutic apheresis systems; and cell expansion systems for biotech and cell processing. The company was formerly known as The Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

19,263 Employees
Last Reported Date: 06/25/14
Founded in 1921

terumo corp-unspon adr (TRUMY) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

terumo corp-unspon adr (TRUMY) Key Developments

Terumo Corporation Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2014; Provides Consolidated Earnings Guidance for the Half Year Ending September 2014 and Year Ending March 31, 2015; Provides Interim and Year End Dividend Guidance for the Year Ending March 31, 2015

Terumo Corporation announced consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales of JPY 114,945 million compared to JPY 111,090 million, operating income of JPY 16,114 million compared to JPY 13,329 million, ordinary income of JPY 14,449 million compared to JPY 12,940 million and net income of JPY 8,394 million or JPY 22.10 per diluted share compared to JPY 8,956 million or JPY 23.58 per basic share for the last year. Income before income taxes and minority interests was JPY 13,765 million compared to JPY 12,608 million for the last year. The company provided year end dividend guidance of JPY 14.50 per share and total dividend of JPY 29 per share for the year ending March 31, 2015 compared to year end dividend guidance of JPY 29 per share and total dividend of JPY 58 per share a year ago. The company provided interim dividend guidance of JPY 14.50 per share compared to JPY 29 per share a year ago. The company provided earnings guidance for the year ending March 31, 2015. For the year, the company expects net sales of JPY 488,000 million, operating income of JPY 64,000 million, ordinary income of JPY 62,000 million and net income of JPY 37,500 million or JPY 98.75 per share. The company provided earnings guidance for the half year ending September 2014. For the half year, the company expects net sales of JPY 236,000 million, operating income of JPY 28,000 million, ordinary income of JPY 27,000 million and net income of JPY 16,000 million or JPY 42.13 per share.

Terumo Corporation, Q1 2015 Earnings Call, Aug 06, 2014

Terumo Corporation, Q1 2015 Earnings Call, Aug 06, 2014

Terumo Corporation Presents at Bank of America Merrill Lynch Japan Conference 2014, Sep-10-2014 04:00 PM

Terumo Corporation Presents at Bank of America Merrill Lynch Japan Conference 2014, Sep-10-2014 04:00 PM. Venue: Grand Hyatt Tokyo, Tokyo, Japan. Speakers: Shinjiro Sato, Senior Executive Officer, Director and President of Cardiac & Vascular Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRUMY:US $24.70 USD 0.00

TRUMY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $46.51 USD +0.01
Getinge AB kr184.00 SEK -1.90
Hospira Inc $53.67 USD +0.42
St Jude Medical Inc $63.50 USD +0.74
Teleflex Inc $109.03 USD -0.47
View Industry Companies
 

Industry Analysis

TRUMY

Industry Average

Valuation TRUMY Industry Range
Price/Earnings 27.5x
Price/Sales 2.0x
Price/Book 1.9x
Price/Cash Flow 27.5x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TERUMO CORP-UNSPON ADR, please visit www.terumo.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.